| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-06 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |